SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
German Primate Center · University of Göttingen · +12 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
21,309
total citations
- FWCI
- 476.72
- Percentile
- 100%
- References
- 67
Citations per year
Authors
13- MHMarkus HoffmannCorresponding
German Primate Center
- HKHannah Kleine‐Weber
German Primate Center, University of Göttingen
- SSSimon Schroeder
Humboldt-Universität zu Berlin, German Center for Infection Research, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Charité - Universitätsmedizin Berlin
- NKNadine Krüger
University of Veterinary Medicine Hannover, Foundation, Hannover Re (Germany)
- THTanja Herrler
Berufsgenossenschaftliche Unfallklinik Murnau
Topics & keywords
Topics
Keywords
- TMPRSS2
- Proteases
- Biology
- Viral entry
- Virology
- Coronavirus
- Protease
- Receptor
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.